Gilead Sciences | GILD - Stock

Stock Price
152.61
Daily Change
3.24 2.17%
Monthly
22.73%
Yearly
58.90%
Q1 Forecast
137.58

Gilead Sciences reported $1.78B in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
AbbVie USD 4.94B 22M Sep/2025
Agios Pharmaceuticals USD 32.03M 1.19M Sep/2025
ALKERMES USD 191M 927K Sep/2025
Alnylam Pharmaceuticals USD 75.38M 3.7M Sep/2025
Amgen USD 6.22B 121M Dec/2025
Biogen USD 2.17B 41.3M Dec/2025
BioMarin Pharmaceutical USD 1.38B 42M Sep/2025
Bristol-Myers Squibb USD 2.76B 21M Sep/2025
Eli Lilly USD 12.18B 1.17B Sep/2025
Gilead Sciences USD 1.78B 40M Sep/2025
GlaxoSmithKline GBP 6.12B 46M Sep/2025
Glaxosmithkline GBP 6.12B 46M Sep/2025
Incyte USD 83.45M 24K Sep/2025
J&J USD 14.15B 734M Sep/2025
Merck USD 6.44B 157M Sep/2025
Moderna USD 332M 92M Sep/2025
Neurocrine Biosciences USD 69.3M 12.4M Sep/2025
Novartis USD 6.42B 114M Sep/2025
Pfizer USD 11.47B 201M Sep/2025
PTC Therapeutics USD 52.69M 18.63M Sep/2025
Regeneron Pharmaceuticals USD 3.2B 53.6M Dec/2025
Sanofi EUR 22.69B 1.81B Dec/2025
Sarepta Therapeutics USD 1.08B 83.13M Sep/2025
United Therapeutics USD 176.5M 7.3M Sep/2025
Vertex Pharmaceuticals USD 1.63B 127.5M Sep/2025